证券记录 · 已归档季度
AMRX
Amneal Pharmaceuticals, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
18被追踪持有人
0Δ持有人
61.16M持有股份
$612.26M报告持仓市值
+0新建仓位
−0清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 +1.7% · 净新建仓位 0.0% — 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 101 | -4 | 106.56M | $1.84B | +7 | −10 |
| Q1 2026 | 107 | -1 | 100.53M | $1.25B | +9 | −11 |
| Q4 2025 | 109 | 0 | 106.30M | $1.34B | +1 | — |
| Q3 2025 | 18 | 0 | 61.16M | $612.26M | — | — |
| Q2 2025 | 15 | -1 | 52.63M | $425.79M | — | −1 |
| Q1 2025 | 13 | +3 | 21.14M | $177.14M | +3 | — |
| Q4 2024 | 10 | -1 | 20.64M | $163.48M | — | −1 |
| Q3 2024 | 10 | 0 | 16.87M | $140.36M | +2 | −2 |
| Q2 2024 | 10 | — | 16.56M | $105.19M | — | — |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 17.95M | +2.3% | $179.73M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | The Vanguard Group ✦ (被动) | 17.95M | +2.3% | $179.73M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | The Vanguard Group ✦ (被动) | 17.95M | +2.3% | $179.73M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | The Vanguard Group ✦ (被动) | 17.95M | +2.3% | $179.73M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | The Vanguard Group ✦ (被动) | 17.95M | +2.3% | $179.73M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | BlackRock ✦ (被动) | 14.07M | +16.0% | $140.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | BlackRock ✦ (被动) | 14.07M | +16.0% | $140.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | BlackRock ✦ (被动) | 14.07M | +16.0% | $140.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | BlackRock ✦ (被动) | 14.07M | +16.0% | $140.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | BlackRock ✦ (被动) | 14.07M | +16.0% | $140.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | BlackRock ✦ (被动) | 14.07M | +16.0% | $140.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | BlackRock ✦ (被动) | 14.07M | +16.0% | $140.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | BlackRock ✦ (被动) | 14.07M | +16.0% | $140.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | BlackRock ✦ (被动) | 14.07M | +16.0% | $140.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | BlackRock ✦ (被动) | 14.07M | +16.0% | $140.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | BlackRock ✦ (被动) | 14.07M | +16.0% | $140.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | BlackRock ✦ (被动) | 14.07M | +16.0% | $140.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | BlackRock ✦ (被动) | 14.07M | +16.0% | $140.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | BlackRock ✦ (被动) | 14.07M | +16.0% | $140.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 20 | BlackRock ✦ (被动) | 14.07M | +16.0% | $140.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | Citadel Advisors ✦ | 5.73M | +1.9% | $57.35M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 22 | Citadel Advisors ✦ | 5.73M | +1.9% | $57.35M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 23 | Geode Capital Management ✦ (被动) | 4.03M | +7.3% | $40.39M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 24 | Geode Capital Management ✦ (被动) | 4.03M | +7.3% | $40.39M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 25 | State Street Global Advisors ✦ (被动) | 3.97M | +1.5% | $39.78M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 26 | Morgan Stanley ✦ | 3.50M | — | $35.07M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Morgan Stanley ✦ | 3.50M | — | $35.07M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Morgan Stanley ✦ | 3.50M | — | $35.07M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Morgan Stanley ✦ | 3.50M | — | $35.07M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Morgan Stanley ✦ | 3.50M | — | $35.07M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Morgan Stanley ✦ | 3.50M | — | $35.07M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Morgan Stanley ✦ | 3.50M | — | $35.07M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | Millennium Management ✦ | 3.33M | -33.9% | $33.36M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 34 | Goldman Sachs Group ✦ | 2.46M | — | $24.63M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | Goldman Sachs Group ✦ | 2.46M | — | $24.63M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Goldman Sachs Group ✦ | 2.46M | — | $24.63M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | Goldman Sachs Group ✦ | 2.46M | — | $24.63M | 0.0% | n/c | 1 | SEC ↗ |
| 38 | D. E. Shaw & Co. ✦ | 1.57M | +69.5% | $15.67M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 39 | D. E. Shaw & Co. ✦ | 1.57M | +69.5% | $15.67M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 40 | JPMorgan Chase ✦ | 1.54M | — | $15.44M | 0.0% | n/c | 1 | SEC ↗ |
| 41 | JPMorgan Chase ✦ | 1.54M | — | $15.44M | 0.0% | n/c | 1 | SEC ↗ |
| 42 | JPMorgan Chase ✦ | 1.54M | — | $15.44M | 0.0% | n/c | 1 | SEC ↗ |
| 43 | JPMorgan Chase ✦ | 1.54M | — | $15.44M | 0.0% | n/c | 1 | SEC ↗ |
| 44 | JPMorgan Chase ✦ | 1.54M | — | $15.44M | 0.0% | n/c | 1 | SEC ↗ |
| 45 | JPMorgan Chase ✦ | 1.54M | — | $15.44M | 0.0% | n/c | 1 | SEC ↗ |
| 46 | JPMorgan Chase ✦ | 1.54M | — | $15.44M | 0.0% | n/c | 1 | SEC ↗ |
| 47 | JPMorgan Chase ✦ | 1.54M | — | $15.44M | 0.0% | n/c | 1 | SEC ↗ |
| 48 | JPMorgan Chase ✦ | 1.54M | — | $15.44M | 0.0% | n/c | 1 | SEC ↗ |
| 49 | JPMorgan Chase ✦ | 1.54M | — | $15.44M | 0.0% | n/c | 1 | SEC ↗ |
| 50 | Arrowstreet Capital ✦ | 1.30M | -23.5% | $12.99M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 51 | AQR Capital Management ✦ | 1.01M | -0.5% | $10.15M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 52 | AQR Capital Management ✦ | 1.01M | -0.5% | $10.15M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 53 | AQR Capital Management ✦ | 1.01M | -0.5% | $10.15M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 54 | AQR Capital Management ✦ | 1.01M | -0.5% | $10.15M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 55 | AQR Capital Management ✦ | 1.01M | -0.5% | $10.15M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 56 | Fidelity (FMR) ✦ | 293.57K | +11.3% | $2.94M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 57 | Fidelity (FMR) ✦ | 293.57K | +11.3% | $2.94M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 58 | T. Rowe Price ✦ | 137.69K | +5.4% | $1.38M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 59 | Renaissance Technologies ✦ | 89.90K | -79.0% | $899,899 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 60 | Two Sigma Investments ✦ | 69.53K | +291.9% | $696,035 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 61 | Wellington Management ✦ | 66.08K | +0.7% | $661,431 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 62 | Wellington Management ✦ | 66.08K | +0.7% | $661,431 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 63 | Wellington Management ✦ | 66.08K | +0.7% | $661,431 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 64 | Wellington Management ✦ | 66.08K | +0.7% | $661,431 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 65 | Gotham Asset Management ✦ | 25.66K | -57.4% | $256,857 | 0.0% | ▼ Trim | 5 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 314 持有人, 158.91M 股份, $1.92B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 13
Kiely John
Director · 50.00K 股 · $882,000
Aug 12
Shah Nikita
Officer · 146.40K 股 · $2.56M
Aug 12
Daly Jason B.
Officer · 210.00K 股 · $3.65M
Aug 11
Daly Jason B.
Officer · 6.61K 股 · $117,050
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 12
SC 13D/A — Patel Tushar Bhikhubhai
17.6% 占股份类别 · 查看 SEC 原始申报文件 ↗
Aug 12
SC 13D/A — Patel Chirag K.
8.4% 占股份类别 · 查看 SEC 原始申报文件 ↗
Aug 12
SC 13D/A — Patel Chintu
9.4% 占股份类别 · 查看 SEC 原始申报文件 ↗
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据